The Morning Leverage: Three Executives Team Up to Target Taiwan

Investment firm Strathspey Crown appears to be embracing the uncertainties surrounding health-care reform with open arms. While some private equity firms facing these uncertainties have moved to safer territories of investing such as health-care information technology and billing management, other are treading in slightly riskier areas where portfolio companies’ revenue is directly linked to reimbursments.

The Newport Beach, Calif., firm — set up by Robert Grant, a former cheif executive and president of Bausch & Lomb Inc.’s surgical unit and president of Allergan Inc.’s Allergan Medical business — is taking a different tack. Mr. Grant has set up a company that invests solely in the lifestyle-oriented segment of the health-care industry where medical bills are entirely paid for by users rather than payors such as insurers and the government.